Oak review
Oak is a compounded semaglutide and tirzepatide program sold under six different legal entities across its own pages, with a longevity, ED and skincare line behind the same quiz — and it is the only program reviewed here whose price you cannot see before you hand over your medical history: its checkout returns zero for every product it sells, and the five figures it advertises publicly contradict one another.
Oak publishes its price before the medical intake — you can see what it costs without handing over your health history first.
On this page
- Semaglutide
- $250/mo at every dose on its order form, read the afternoon of 15 August 2026 — it showed $200/mo that morning
- Tirzepatide
- $300/mo at every dose on its order form, read the afternoon of 15 August 2026 — it showed $250/mo that morning
- Coverage
- Not published — its terms say 45 states and point at a list on an FAQ page that does not exist
- Price visible
- Before intake
The verdict
Oak prints its price before the medical intake, which is the entry condition rather than the finish, and gives some of it back on the rest of the question — what the advertised figure is attached to, or who fills the prescription. It lands at 13 of 31.
The number beside Oak's name answers one question — can you find out what this costs before you hand over your medical history? — and it is dominated by that. A program is credited for naming the pharmacies that compound its medicine and for a certification whose seal actually resolves, and docked when the advertised rate needs a commitment, when a second fee sits outside it, when the seller's own terms say the published figure is not what it will charge, and when the FDA has a warning letter on file. What the price turns out to be is not an input at all, which is why a cheaper program can sit below a dearer one here.
Who it is for, and who it is not
A good fit if
You want to compare before you hand anything over
Oak publishes what it charges before the medical intake, so you can weigh it against anything else on this page without first giving a company your health history.
Look elsewhere if
You want to check the pharmacy
Oak does not publicly name the compounding pharmacy that fills its prescriptions. That is common and it is not an accusation, but the one thing you would most want to verify about a compounded medicine is the one thing you cannot.
What it actually costs
Both figures below are reproduced exactly as we recorded them, with every condition attached. They are long on purpose: a monthly rate quoted without the term that buys it, the cadence it is billed on, or the dose it applies to is the single most common way a price on a page like this turns out to be untrue.
$250/mo at every dose on its order form, read the afternoon of 15 August 2026 — it showed $200/mo that morning
$300/mo at every dose on its order form, read the afternoon of 15 August 2026 — it showed $250/mo that morning
Not published — its terms say 45 states and point at a list on an FAQ page that does not exist
Oak pays us a commission if you start care through this link — as does every company with a review here, which is what decides who gets one, so this is not a survey of the market. See our disclosure, and weigh the trade-offs above against the evidence rather than taking our word for it. Oak sells a prescription medicine, not a probiotic; this site's ranked shelf is the metabolic probiotic ranking, and a supplement is a different decision from a drug.
The pharmacy behind the medicine
It does not name its pharmacy. Oak does not publicly disclose which compounding pharmacy fills its prescriptions. That is common and it is not an accusation — but it does mean the one thing you would most want to verify about a compounded medicine is the one thing you cannot.
A compounded drug is mixed to order by a pharmacy rather than manufactured and released as a finished product, so the FDA has not reviewed the specific preparation you are prescribed for safety, effectiveness or quality. That is true of every compounded program on this page, including the ones that score highest, and it is the most important sentence on it.
The honest read
What it does well
- It sells both molecules, and its intake needs no video call for an initial approval
- There is no minimum term and no contract: its own terms give it cancellable at any time
- Free shipping and free health coaching are stated as included rather than added at checkout
- Its catalog is broader than the marketing suggests — the same account also runs an anti-aging program (NAD+, glutathione, MIC+B12, metformin), a sermorelin and tesamorelin program, ED and a compounded skincare line
What to check first
- ⚠ Its price does not hold still. Its order form showed $200/mo semaglutide and $250 tirzepatide on the morning of 15 August 2026 and $250 and $300 that same afternoon — same page, same route in, browser storage cleared — with every brand-name line $100 higher and the discount strike-throughs gone. Whatever you are quoted, check it again before you pay
- ⚠ You will not find that price in its advertising. The figure is on the first screen of its order form, but the page its affiliate links open shows no price at all, and its marketing pages carry nine different "starting" figures — $119, $133, $160, $167, $180, $185, $190, $199 and $250 — none of which is what it charges
- It advertises five GLP-1 prices that do not agree with each other: $119 semaglutide and $185 tirzepatide in the hero and the product cards, $133 and $199 in its own meta and social descriptions, $167 a month in the "How Oak Compares" table on the homepage and /product, $190 in the same table on /weightloss, and $119 again in the homepage FAQ
- Its non-GLP-1 lines — NAD+, glutathione, MIC+B12, metformin, sermorelin, tesamorelin, phentermine, ED and skincare — carry no published price of any kind, anywhere on the site
- A "$200 off new patient offer" and a "Save up to 60% vs retail" banner run with no published mechanics and no resulting price, on top of figures that already disagree
- Six different legal entities appear across its own pages. Four are on one terms-of-use page — Oak Longevity Holdings Corp, Oak Longevity Corp, Leaf Longevity Holdings Corp. DBA Oak Longevity, and Oaklovesyou LLC, the last inside a second, separately dated Terms of Use appended below the first — and the homepage footer adds two more, Flow Longevity Holdings Corp and Mito Health Holdings Corp
- Its state coverage is a circular reference: one terms document says 45 states, the other makes eligibility depend on a list "found in our FAQ", and that FAQ does not exist — /faq, /faqs, /help and /states all return 404 and the sitemap has no FAQ page
- It names no compounding pharmacy and no clinician: no medical director, no NPI, nobody. Its own consent forms reveal the prescribing network is Beluga Health, which the marketing never mentions
- There is no LegitScript seal id to check. The footer links to LegitScript's keyword checker and renders a local SVG rather than an issued seal image, so the certification cannot be verified and we do not claim it
- Its hero says "No subscriptions" four times while its terms describe "your Subscription fee" and how to cancel "your subscription"
- Its homepage ships a live Women's Health tile wired to the anti-aging program — the NAD+ and glutathione intake — while /weight-loss and /start label Women's Health "Coming Soon", and no women's-health questionnaire exists in its catalog at all
- Refunds are a hard no once a prescription is sent to the pharmacy, in its own words even if you try to stop, hold, reroute, return or cancel the shipment with the carrier directly, under binding AAA arbitration with class actions waived
- Its social proof does not agree with itself either: "Trusted by 50,000+" on /product against "10,000+ Satisfied Patients" and "Trusted by 5,000+ members" on the homepage
- Compounded semaglutide and tirzepatide are not FDA-approved products. Oak does sell a brand-name route — Ozempic $1,250/mo, Zepbound $1,350/mo, Mounjaro from $1,200 and Wegovy from $1,500 — but at five to six times the compounded price, and those lines are a 4-WEEK supply, so a "month" there is 13 charges a year
- Compounded medications are not FDA-approved finished products
How it compares
Oak sits at 13 of 31 on this page. Every prescription GLP-1 program this site links out to is scored on the same question: can you see the price before you hand over your health history? The full list is on the prescription GLP-1 review index.
Because Oak prints a figure before the intake rather than after it, it is also a ranked row on our GLP-1 telehealth ranking, our compounded semaglutide ranking and our compounded tirzepatide ranking. Each is this same question narrowed to the programs that answer it, with every figure printed as we recorded it and its conditions attached rather than trimmed to fit a column.
- Care Bare Rx review
$199/mo at the 0.25 mg tier (compounded weekly injection; $249 at 0.5 and 1 mg, $299 at 1.5 and 2 mg)
- Synergy Rx review
$199/mo month-to-month (compounded weekly injection; the 3-month bundle is $748, or $249/mo — dearer, not cheaper; sublingual tablets $299/mo)Show the full pricing note
- Telos Rx review
From $99/mo (compounded weekly injection, the same price at every dose — but this is the longest-plan floor, and the month-to-month rate appears only inside the intake)Show the full pricing note
- Wellorithm review
From $147/mo compounded, the same figure whether you take the injection or the oral dissolving tablet, with "$100 off your first month" printed beneath it and nothing saying whether $147 is the standing rate or the discounted oneShow the full pricing note
- He & She MD review
$199/mo month-to-month (its own plan page; $1,188 once for a year is the $99/mo the banners quote)
Read this before you start
Checked on Oak's own site on . Prices change — confirm on Oak's own site before you commit. This page is informational and not medical advice: a GLP-1 is a prescription drug, and whether one suits you is a decision for a licensed clinician who knows your history. How we choose what appears here, and what we are paid for, is set out in our editorial policy.